Tharimmune Inc share price logo

Tharimmune Inc Share Price

NASDAQ: THAR

Small Cap

$3.15

+0.28

(+9.93%)

as on

Tharimmune Inc Stock Performance

as on October 21, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $2.91
    $3.18
    downward going graph

    7.62%

    Downside

    0.95%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.95
    $9.08
    downward going graph

    69.78%

    Downside

    188.25%

    Upside

    downward going graph

Tharimmune Inc share price movements today

Previous Close
$2.87
Open
$2.93
Volume
458.5K
Day's Low - High
$2.91 - $3.18
52 Week Low - High
$0.95 - $9.08

Tharimmune Inc Historical Returns

1 Month Return
-12.22 %
3 Month Return
+ 89.9 %
1 Year Return
+ 47.66 %
3 Year Return
0 %
5 Year Return
0 %

Tharimmune Inc Stock Fundamentals & Key Indicators

Check Tharimmune Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$19.5M

EPS (TTM)

-7.06

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

16626300.00%

Tharimmune Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Tharimmune Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
SELL$19.5MNANA0.00%
BUY$35.5B359.02%-16.34-259.82%
BUY$63.1B259.92%-505.15-12.96%
BUY$106.9B98.27%29.6731.86%
BUY$61.3B0.76%14.5831.37%

Stock Returns calculator for Tharimmune Inc Stock including INR - Dollar returns

The Tharimmune Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

Tharimmune Inc investment value today

Current value as on today

₹1,52,004

Returns

₹52,004

(+52%)

Returns from Tharimmune Inc Stock

₹47,196 (+47.2%)

Dollar Returns*

₹4,808 (+4.81%)

Analyst Recommendation on Tharimmune Inc Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Tharimmune Inc. Average target price of $5

Tharimmune Inc Share Price Target

Get share price movements and forecasts by analysts on Tharimmune Inc.

What analysts predicted

37%UPSIDE

Target Price

$5

Current Price

$3.15

Analyzed by

6 Analysts

Target

$5.00

Tharimmune Inc target price $5, a slight upside of 37% compared to current price of $3.15. According to 6 analysts rating.

Tharimmune Inc Stock’s Investor Sentiment and Interest

Search interest for Tharimmune Inc Stock has decreased by -92% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-92% versus previous 30 day period

Tharimmune Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-2
-2
-1
-2
-2
-2
-3
-3
-2
-1
EBITDA
-2
-2
-1
-2
-2
-2
-3
-3
-2
-1
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-2
-2
-1
-2
-2
-2
-3
-3
-2
-1
Income Tax Expense
0
0
0
0
0
-
-
0
-
-
Net Income
-2
-2
-1
-2
-2
-2
-3
-3
-2
-1
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Tharimmune Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
Operating Income
0
-1
-3
-6
-9
-12
EBITDA
-1
-1
-1
-6
-9
-12
Interest Expense
0
0
0
1
0
0
Depreciation
-
-
-
-
-
-
Income Before Tax
-1
-2
-2
-8
-9
-12
Income Tax Expense
0
0
0
0
0
-12
Net Income
-1
-2
-2
-8
-9
-12
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Tharimmune Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-2
-1
-2
-2
-2
-3
-3
-2
-1
Operating Cash Flow
-1
0
-1
-2
-2
-2
-3
-2
-1
Investing Cash Flow
-
-
-
-
-
0
-
-
-
Financing Cash Flow
1
0
9
0
1
0
1
0
2
Change in Cash
0
-1
8
-2
0
-3
-1
-2
1

Tharimmune Inc Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-2
-2
-8
-9
-12
Operating Cash Flow
-1
-1
-6
-7
-10
Investing Cash Flow
-
-
-
-
-
Financing Cash Flow
1
0
13
11
3
Change in Cash
0
0
6
4
-7

Tharimmune Inc News & Key Events

  • img

    Today's Timeline - 21 August

    Thu, 01:15 PM

    -

    Tharimmune announces positive simulation results for TH104, leading to a 207% stock price surge.

Insights on Tharimmune Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, THAR stock has moved up by 89.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Insmed Incorporated has given 132.3% return, outperforming this stock by 84.6%

About Tharimmune Inc

Tharimmune, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing therapeutic candidates for inflammatory and immunologic conditions with unmet need. It has a transmucosal film product, TH104, is a Phase II ready clinical candidate and an oral biologic as well as two bispecific biologics in pre-clinical development. TH104 is a transmucosal buccal film embedded with the active compound nalmefene onto a thin film which adheres inside of the mouth on the cheek and biodegrades. TH104 is an ideal product candidate for multiple liver-related and other pruritogenic inflammatory conditions. It is also developing an early-stage pipeline of novel therapeutic candidates targeting validated high value immune-oncology targets including human epidermal growth factor receptor 2, human EGF receptor 3 and programmed cell death protein. The Company is developing antibodies, including bispecific antibodies, antibody drug conjugates, among others.
OrganisationTharimmune Inc
Headquarters1200 Route 22 East, Bridgewater, NJ, United States, 08807
CEOMr. Sireesh Appajosyula Pharm.D.
E-voting on sharesClick here to vote

Key Management of Tharimmune Inc

Name

Title

Mr. Sireesh Appajosyula Pharm.D.

CEO & Director

Mr. Vincent LoPriore

Executive Chairman of the Board

Mr. Dong Kim

Chief Financial Officer

FAQs

What is Tharimmune Inc share price today?

Tharimmune Inc share price today is $3.15 as on at the close of the market. Tharimmune Inc share today touched a day high of $3.18 and a low of $2.91.

What is the 52 week high and 52 week low for Tharimmune Inc share?

Tharimmune Inc share touched a 52 week high of $9.08 on and a 52 week low of $0.95 on . Tharimmune Inc stock price today i.e. is closed at $3.15,which is 65.31% down from its 52 week high and 230.88% up from its 52 week low.

What is Tharimmune Inc's market capitalisation today?

Tharimmune Inc market capitalisation is $0.00T as on .

How to invest in Tharimmune Inc Stock (THAR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Tharimmune Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tharimmune Inc Shares that will get you 0.4762 shares as per Tharimmune Inc share price of $3.15 per share as on October 21, 2025 at 1:29 am IST.

What is the minimum amount required to buy Tharimmune Inc Stock (THAR) from India?

Indian investors can start investing in Tharimmune Inc (THAR) shares with as little as ₹87.965 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.65 in Tharimmune Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Tharimmune Inc share’s latest price of $3.15 as on October 21, 2025 at 1:29 am IST, you will get 3.1746 shares of Tharimmune Inc. Learn more about fractional shares .